NCT06147479Completed
Cognitive Stimulation in Daily Activities for People Living With Early to Middle Stage Dementia
Cognitive Stimulation in Activities of Daily Living for Individuals Living With Mild-to-Moderate Dementia (CS-ADL): a Pilot Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 6 Aug 2024
Brief summary (registry, in English)
The goal of this study is to test the effect of CS-ADL is on people living with early to middle stage dementia. The study also aims to evaluate the feasibility of conducting larger-scale research of CS-ADL. The main questions it aims to answer are: * What is the effect of CS-ADL on the ability of people with early to middle stage dementia to carry out their everyday activities? * What is the effect of CS-ADL on the memory, mood, communication, and quality of life of people living with early to middle stage dementia? What is the feasibility of conducting large-scale research of CS-ADL? Participants will take part in a group program that lasts 7 weeks, with one session per week, lasting two hours. Participants will take part in rewarding and stimulating activities, for example discussion, reminiscence, music, and practical activities such as baking, cooking, gardening. Participants will be asked to complete a variety of questionnaires before and after taking part in the group. Researchers will compare a group receiving CS-ADL to a group receiving their usual care, to explore whether CS-ADL works well in comparison to typical treatment provided by the health services.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 15 Nov 2023
- Start date
- 3 Nov 2023
- Primary completion date
- 21 Jun 2024
- Lead sponsor
- National University of Ireland, Galway, Ireland
- NCT number
- NCT06147479
What you commit to
- Study type: Interventional
- Participants enrolled: 16
- From 3 Nov 2023 to the primary completion date, 21 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with severe dementia, i.e., an MMSE\<10, will be excluded as most CS interventions are not applicable for those with severe cognitive impairment.
- A significant physical illness/disability that may affect participation during intervention sessions or assessments.
Other
- Participants will be excluded if they have significant uncontrolled disruptive behaviours.
- Premorbid diagnosis of a learning disability.
Who the study is looking for
- Participants must have a formal diagnosis of major neurocognitive disorder (dementia) as per the DSM-V criteria.
- Participants must have a mild-to-moderate cognitive impairment as classified by the Montreal Cognitive Assessment (MoCA).
- Participants must have some ability to communicate and understand communication, determined by a score of 1 or 0 on questions 12 and 13 of the Clifton Assessment Procedures for the Elderly-Behaviour Rating Scale.
- Participants must be able to see and hear well enough to participate in the group.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Galway Coordinator of this site? Confirm its status | Galway | Ireland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.